… medicines as a unique category of therapeutic agents, efforts are being made … development and approval of nanoparticle-based therapeutics, and discusses potential strategies for drug …
… , it is important that we develop novel anti-influenza drugs with broad reactivity against all strains and subtypes, and consider moving to multiple drugtherapy in the future. In this article …
MA Chavez, AC White Jr - Expert Review of Anti-Infective Therapy, 2018 - Taylor & Francis
… novel drugs and new compounds for the treatment of cryptosporidiosis. … development of resistance suggests that we may eventually require drug combinations for optimal therapy…
AR Green, A Shuaib - Drug discovery today, 2006 - Elsevier
… Confidence in the correctness of this drugdevelopment approach to the treatment of acute … so-called SAINT I trial) because the drug was found to significantly reduce disability (using the …
E Espinosa, P Zamora, J Feliu, MG Barón - Cancer treatment reviews, 2003 - Elsevier
… These problems are delaying the development of antisense therapy. Another drug in this group is angiozyme, which blocks the mRNA of the vascular endothelial growth factor [28], [29]. …
… Given such high success rates, what could be the role of therapeuticdrug monitoring (TDM) in the treatment of TB? This paper explores those circumstances where the risk of treatment …
AM Ginsberg, M Spigelman - Nature medicine, 2007 - nature.com
… despite appropriate drugtreatment are … therapy can be conceived as having four primary goals: shortening and simplifying the treatment of active, drug-sensitive TB; improving therapy …
… The interval between initiation of therapy with etanercept or infliximab and the development of … -TNF treatment, in the absence of specific cytotoxic therapy directed toward the lymphoma. …
… in drug design can have a profound impact on drug synergism and antagonism. A systematic combination therapydevelopment … drug dose ratios that result in globally optimal treatment …